Skip to main content
. 2019 Feb 20;17(4):3981–3989. doi: 10.3892/ol.2019.10059

Figure 2.

Figure 2.

Anti-proliferation effects of ruxolitinib in breast cancer cells. (A and B) Effects of ruxolitinib on the cell proliferation of (A) MCF-7 and (B) TAMR-MCF-7 cells. MCF-7 and TAMR-MCF-7 cells were cultured in 96-well plate and cell proliferation was determined by IncuCyte ZOOM live-cell analysis system for 96 h. Data represent means ± standard deviation (n=6). ***P<0.005 vs. vehicle-treated control. Rxb, ruxolitinib; TAMR, tamoxifen resistant.